M. Schetz

Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: a possible alternative to oral anticoagulants.

B. Meyns, J. Arnout, B. Meuris, 2007, Artificial organs.

Steroid‐free immunosuppression during and after liver transplantation – a 3‐yr follow‐up report

T. Roskams, F. Nevens, J. Fevery, 2003, Clinical transplantation.

Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?

J. Wester, H. O. Oudemans-van Straaten, M. Schetz, 2006, Intensive Care Medicine.

Combined liver and (heart-)lung transplantation in liver transplant candidates with refractory portopulmonary hypertension.

G. Verleden, F. Nevens, P. D. De Leyn, 2002, Transplantation.

Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017

L. Forni, W. Druml, H. O. Oudemans-van Straaten, 2017, Intensive Care Medicine.

Reliability of serum creatinine‐based formulae estimating renal function in non‐critically ill surgery patients: Focus on augmented renal clearance

B. Meijers, S. Nijs, I. Spriet, 2018, Journal of clinical pharmacy and therapeutics.

Prevention of acute kidney injury and protection of renal function in the intensive care unit

L. Forni, C. Ronco, W. Druml, 2010, Intensive Care Medicine.